Care standards for gender dysphoria are already being reshaped across Europe, in Brazil, and the U.S.

You can save this article by registering for free here. Or sign-in if you have an account.

On May 1, the U.S. Department of Health and Human Services (HHS) released a bombshell 409-page report laying bare the troubling state of paediatric gender medicine. This moment presents yet another opportunity for Canada to reckon with a medical scandal that has long gone unaddressed.

Enjoy the latest local, national and international news.

Enjoy the latest local, national and international news.

Create an account or sign in to continue with your reading experience.

Create an account or sign in to continue with your reading experience.

The HHS report highlights the exceptionally weak evidence used to support puberty blockers, cross-sex hormones, and surgeries for youth who identify as transgender, exposing how ideology dominates over science in the field of gender medicine. Its conclusion is damning: the medical establishment has failed vulnerable young people.

The review was commissioned by an executive order from U.S. President Donald Trump, whose directive was laced with politically charged and inflammatory language. In sharp contrast, the report itself is measured and grounded in evidence. Its recommendations echo the cautious, evidence-based approach to youth gender care now taking hold across much of Europe, contradicting the ideological positions of all major medical associations in the U.S. and Canada. 

This newsletter tackles hot topics with boldness, verve and wit. (Subscriber-exclusive edition on Fridays)

By signing up you consent to........

© National Post